As of 4:00pm ET
| -0.07 / -1.12%|
The 2 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 5.00. The median estimate represents a +29.03% increase from the last price of 6.20.
The current consensus among 2 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.